Subject(s)
Bone Marrow/virology , COVID-19/complications , Pancytopenia/etiology , SARS-CoV-2/pathogenicity , Waldenstrom Macroglobulinemia/complications , Bone Marrow/pathology , COVID-19/pathology , COVID-19/virology , Fatal Outcome , Female , Humans , Middle Aged , Pancytopenia/pathology , Pancytopenia/virology , SARS-CoV-2/isolation & purification , Waldenstrom Macroglobulinemia/pathology , Waldenstrom Macroglobulinemia/virologyABSTRACT
INTRODUCTION: Occult hepatitis B virus (HBV) infection, defined as negative hepatitis B surface antigen (HBsAg) but detectable HBV DNA in serum and liver tissue, has very rarely been described in cryoglobulinemia (CG) patients. This case report sheds light on the possible link between occult HBV infection and CG. PATIENT CONCERNS: A 76-year-old man presented with rapidly deteriorating renal function within 1 year. DIAGNOSIS: Cryoglobulinemic glomerulonephritis was diagnosed through renal biopsy. Initially, the patient tested negative for HBsAg, but a low HBV viral load was later discovered, indicating an occult HBV infection. Further studies also revealed Waldenström macroglobulinemia (WM). INTERVENTIONS: We treated the patient as WM using plasma exchange and rituximab-based immunosuppressive therapy. OUTCOMES: After 1 cycle of immunosuppressive treatment, there was no improvement of renal function. Shortly after, treatment was discontinued due to an episode of life-threatening pneumonia. Hemodialysis was ultimately required. CONCLUSION: Future studies are needed to explore the link between occult HBV infection and CG, to investigate the mediating role of lymphomagenesis, and to examine the effectiveness of anti-HBV drugs in treating the group of CG patients with occult HBV infection. We encourage clinicians to incorporate HBV viral load testing into the evaluation panel for CG patients especially in HBV-endemic areas, and to test HBV viral load for essential CG patients in whom CG cannot be attributed to any primary disease.
Subject(s)
Cryoglobulinemia/complications , Glomerulonephritis/complications , Hepatitis B/complications , Waldenstrom Macroglobulinemia/etiology , Aged , Cryoglobulinemia/virology , Glomerulonephritis/virology , Hepatitis B Surface Antigens/blood , Humans , Male , Waldenstrom Macroglobulinemia/diagnosis , Waldenstrom Macroglobulinemia/virologyABSTRACT
The association between hepatitis C virus (HCV) infection and risk of malignant lymphoma remains controversial, perhaps due to small-sized studies and low prevalence of HCV in the general population. On the basis of a large Danish-Swedish population-based case-control study, 2,819 lymphoma patients and 1,856 controls of second-generation Danish-Swedish origin were screened for HCV infection using an enzyme-linked immunosorbent assay and a confirming recombinant immunoblot assay (RIBA) test. Positive samples were tested with real-time PCR for the presence of HCV RNA. The association between HCV infection and risk of malignant lymphoma was assessed by logistic regression. When intermediate RIBA test results were interpreted as positive, anti-HCV antibody positivity was associated with a nonsignificant increased risk of non-Hodgkin lymphoma (NHL) overall (odds ratio (OR) = 2.2; 95% confidence interval (CI) 0.9-5.3; n = 20 cases), of B-cell lymphomas combined (OR = 2.4 [1.0-5.8]; n = 20) and of lymphoplasmacytic lymphoma (OR = 5.2 [1.0-26.4]; n = 2). No patients with T-cell or Hodgkin lymphoma were HCV-positive. A more conservative definition of HCV positivity (disregarding intermediate RIBA results) resulted in an OR = 1.6 (0.3-8.5; n = 5) for NHL overall. When the definition was further restricted to require HCV RNA positivity, OR was 1.7 (0.2-16.2; n = 3) for NHL overall. Our findings from a population with a low prevalence of HCV suggest a positive association between HCV and risk of NHL, in particular of B-cell origin.
Subject(s)
Hepatitis C/complications , Lymphoma/epidemiology , Lymphoma/virology , Adult , Aged , Case-Control Studies , Confidence Intervals , Denmark/epidemiology , Enzyme-Linked Immunosorbent Assay , Female , Humans , Immunoblotting , Leukemia, Lymphocytic, Chronic, B-Cell/epidemiology , Leukemia, Lymphocytic, Chronic, B-Cell/virology , Logistic Models , Lymphoma, AIDS-Related/epidemiology , Lymphoma, AIDS-Related/virology , Lymphoma, B-Cell/epidemiology , Lymphoma, B-Cell/virology , Lymphoma, Follicular/epidemiology , Lymphoma, Follicular/virology , Lymphoma, Non-Hodgkin/epidemiology , Lymphoma, Non-Hodgkin/virology , Male , Middle Aged , Odds Ratio , RNA, Viral/isolation & purification , Reverse Transcriptase Polymerase Chain Reaction , Risk Factors , Sweden/epidemiology , Waldenstrom Macroglobulinemia/epidemiology , Waldenstrom Macroglobulinemia/virologyABSTRACT
CONTEXT: Hepatitis C virus (HCV) infection causes liver cancer and cirrhosis and may also increase the risk of other tumors, particularly hematopoietic malignancies and thyroid cancer. Previous studies have been too small to adequately assess these risks. OBJECTIVE: To test the hypothesis that HCV infection is associated with increased risk for hematological malignancies, related lymphoproliferative disorders, and thyroid cancer. DESIGN, SETTING, AND PATIENTS: A retrospective cohort study of users of US Veterans Affairs health care facilities from 1997-2004, which included 146,394 patients infected with HCV who had at least 2 visits with a diagnostic code for HCV infection, and 572,293 patients uninfected with HCV. To assemble the HCV-uninfected cohort, we randomly selected up to 4 patients per patient infected with HCV from all veterans who matched on age, sex, and baseline visit date and type (inpatient or outpatient). Individuals with human immunodeficiency virus were excluded. MAIN OUTCOME MEASURES: Risks of hematopoietic malignancies, related lymphoproliferative precursor diseases, and thyroid cancer, adjusting for selection factors, race, era of military service, and use of medical services. RESULTS: The mean (SD) age of the patients was 52 (8) years, and 97% were men. Risks for non-Hodgkin lymphoma (n = 1359), Waldenström macroglobulinemia (n = 165), and cryoglobulinemia (n = 551) were increased with HCV infection (adjusted hazard ratio [HR], 1.28; 95% confidence interval [CI], 1.12-1.45; adjusted HR, 2.76; 95% CI, 2.01-3.79; and adjusted HR, 3.98; 95% CI, 3.36-4.72; respectively). We found no significantly increased risk for other hematological malignancies. Although thyroiditis risk was slightly increased, risk for thyroid cancer (n = 320) was not (adjusted HR, 0.72; 95% CI, 0.52-0.99). Adjusted P values for non-Hodgkin lymphoma, Waldenström macroglobulinemia, cryoglobulinemia, and thyroiditis were all <.0038, the Bonferroni threshold for statistical significance considering multiple comparisons. CONCLUSIONS: Hepatitis C virus infection confers a 20% to 30% increased risk of non-Hodgkin lymphoma overall, and a 3-fold higher risk of Waldenström macroglobulinemia, a low-grade lymphoma. Risks were also increased for cryoglobulinemia. These results support an etiological role for HCV in causing lymphoproliferation and causing non-Hodgkin lymphoma.
Subject(s)
Hepatitis C/complications , Lymphoma, Non-Hodgkin/epidemiology , Lymphoma, Non-Hodgkin/virology , Lymphoproliferative Disorders/epidemiology , Lymphoproliferative Disorders/virology , Thyroid Neoplasms/virology , Veterans/statistics & numerical data , Adult , Aged , Cryoglobulinemia/epidemiology , Cryoglobulinemia/virology , Female , Humans , Male , Middle Aged , Retrospective Studies , Risk , Thyroid Neoplasms/epidemiology , United States , Waldenstrom Macroglobulinemia/epidemiology , Waldenstrom Macroglobulinemia/virologyABSTRACT
Cutaneous manifestations of Waldenström's macroglobulinaemia (WM) include purpura, ulcers, urticaria, leukocytoclastic vasculitis, and immunobullous dermatoses. No association has been reported previously of WM and hepatitis B virus (HBV) infection. A 40-year-old female HBV carrier was admitted to hospital because of generalized oedema, oliguria, haematuria, hypertension, fever and blood-tinged sputum. Cutaneous manifestations included generalized petechiae, palpable purpura mainly on the legs, multiple necrotic ulcerations and gangrenous changes on the toes, and necrotic, giant confluent reticulate purpura on the trunk surmounted by several tense bullae. Laboratory investigations revealed monoclonal gammopathy of IgM kappa type (6.7 g/L), membranoproliferative glomerulonephritis associated with HBV infection, Bence Jones proteinuria, and an increased number of abnormal plasmacytoid cells in the bone marrow. Pathologic examination demonstrated immune complex-mediated vasculitis with deposits of IgM in the walls of dermal vessels and secondary subepidermal bulla formation. HBV infection may have caused WM or modified the clinical course in this fatal case.
Subject(s)
Hepatitis B/complications , Skin Diseases/etiology , Waldenstrom Macroglobulinemia/virology , Adult , Fatal Outcome , Female , Hepatitis B/immunology , Hepatitis B/pathology , Humans , Immune Complex Diseases/complications , Immune Complex Diseases/pathology , Immunoglobulin M/analysis , Skin Diseases/immunology , Skin Diseases/pathology , Vasculitis/immunology , Vasculitis/pathology , Waldenstrom Macroglobulinemia/immunology , Waldenstrom Macroglobulinemia/pathologyABSTRACT
Human herpesvirus type 8 (HHV-8), also known as Kaposi's sarcoma-associated herpesvirus (KSHV) is a new member of the g-herpesvirus family. It is an unusual herpesvirus in that it carries a large number of genes that encode oncoproteins or cell signaling proteins. In addition to being the causative agent of both HIV-associated and non-HIV-associated Kaposi's sarcoma this DNA tumor virus has been implicated in the pathogenesis of several diseases. These include multiple myeloma (MM), Waldenstöm's macroglobulinemia (WM), multicentric Castleman's disease (MCD), body cavity-based lymphoma (BCBL), and various other conditions such as sarcoidosis and pemphigus. While the causative role of the viral infection is fairly certain in the development of BCBL and multicentric Castleman's disease, HHV-8 may act through a different mechanism to induce plasma cell malignancies. It has been suggested though the finding is still controversial - that infection of bone marrow stromal dendritic cells by HHV-8 might be a key factor in the etiology and pathogenesis of monoclonal gammopathies. The aim of this review is to provide a short introduction into the tumorigenic potential of HHV-8 as well as to detail the available data and possible mechanisms on the involvement of this virus in different hematologic diseases.
Subject(s)
Hematologic Diseases/virology , Herpesviridae Infections/virology , Herpesvirus 8, Human/isolation & purification , Tumor Virus Infections/virology , Bone Marrow/virology , Castleman Disease/virology , Dendritic Cells/virology , Hematologic Neoplasms/virology , Herpesviridae Infections/complications , Herpesvirus 8, Human/genetics , Herpesvirus 8, Human/pathogenicity , Humans , Lymphoma, AIDS-Related/virology , Lymphoma, Non-Hodgkin/virology , Multiple Myeloma/virology , Oncogenes , Plasma Cells/pathology , Sarcoma, Kaposi/etiology , Sarcoma, Kaposi/virology , Stromal Cells/virology , Tumor Virus Infections/complications , Waldenstrom Macroglobulinemia/virologySubject(s)
Herpesviridae Infections/epidemiology , Herpesvirus 8, Human/pathogenicity , Multiple Myeloma/etiology , Sexual Partners , Sexually Transmitted Diseases, Viral/epidemiology , Waldenstrom Macroglobulinemia/etiology , Aged , Aged, 80 and over , Antibodies, Viral/blood , Comorbidity , Dendritic Cells/virology , False Negative Reactions , Female , France/epidemiology , HIV Infections/epidemiology , HIV Infections/virology , Herpesviridae Infections/complications , Herpesviridae Infections/transmission , Herpesvirus 8, Human/classification , Herpesvirus 8, Human/immunology , Herpesvirus 8, Human/isolation & purification , Humans , Male , Middle Aged , Multiple Myeloma/epidemiology , Multiple Myeloma/virology , Prevalence , Sarcoma, Kaposi/epidemiology , Sarcoma, Kaposi/virology , Sexually Transmitted Diseases, Viral/complications , Sexually Transmitted Diseases, Viral/transmission , Waldenstrom Macroglobulinemia/epidemiology , Waldenstrom Macroglobulinemia/virologyABSTRACT
Kaposi's sarcoma-associated herpesvirus (KSHV) is suspected to play a role in the aetiology of multiple myeloma. Because of similarities in the pathophysiology of multiple myeloma and Waldenstrom's macroglobulinaemia (WM), we investigated DNA samples from 20 bone marrow biopsies with WM for the detection of KSHV by PCR (KS330/ORF26). We performed two rounds of amplification and found that only 1/20 of the DNA samples obtained from biopsies had a detectable KSHV sequence. The positive patient was also infected by the human immunodeficiency virus (HIV). Our data provide evidence that KSHV cannot be implicated in the pathogenesis of WM.
Subject(s)
Bone Marrow Diseases/virology , DNA, Viral/isolation & purification , Herpesvirus 8, Human/isolation & purification , Sarcoma, Kaposi/virology , Waldenstrom Macroglobulinemia/virology , Humans , Polymerase Chain Reaction/methodsABSTRACT
Italian authors report that hepatitis C virus (HCV) infection may be one of the causes of lymphoid malignancy such as non-Hodgkin's lymphoma (NHL) and Waldenström's macroglobulinemia (WM). To assess the relationship between HCV infection and B cell malignancy (BCM) in Japan, we analyzed HCV-RNA in 50 patients with BCM [25 cases of NHL, 4 of WM and 21 of multiple myeloma (MM)] and determined genotype of infected HCV(Okamoto's classification) using reverse transcription-polymerase chain reaction assay. Eight (16.0%) of 50 patients with BCM were HCV-RNA positive [HCV(+)], while no patients were HCV(+) in control group (18 patients of non-B cell NHL). Numbers of HCV(+) cases in each group examined were as follows; four (16.0%) in B cell NHL (genotype II/III/IV were 3/1/0, respectively), one (25.0%) in WM (genotype III) and three (14.3%) in MM (genotype II/III/IV were 1/1/1, respectively). All patients examined had no symptoms and signs suggesting vasculitis. The incidence of HCV infection in the patients with BCM was markedly higher than that (approximately 1%) of healthy blood donors in Japan. We also experienced four B cell NHL cases with splenic or hepatic origin in the course of chronic hepatitis C. These results implicate the association between persistent HCV infection and the occurrence of BCM.